Inventor
ROGER M. ILAGAN
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C12NMicroorganisms or enzymes29%
F04CRotary-piston, or oscillating-piston, positive-displacement machines for liquids8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
PatentTitleYear
12,310,992Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells202512,274,684Treatment of vasculopathy with prostacyclin and mesenchymal stem cells202512,157,887Bioactive renal cells202411,839,596Treatment of vasculopathy with prostacyclin and mesenchymal stem cells202311,839,631Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells202311,666,602Treatment of pulmonary arterial hypertension with mesenchymal stem cells202311,141,393Treatment of vasculopathy with prostacyclin and mesenchymal stem cells2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to UNITED THERAPEUTICS CORP (6)· patent assignee history
2021–2025Based in US· patent location history
2024Patents assigned to INREGEN (1)· patent assignee history
2024Patents assigned to PROKIDNEY (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNITED THERAPEUTICS CORP | 6 | 2021–2025 |
| INREGEN | 1 | 2024 |
| PROKIDNEY | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |